Transthyretin

23 drugs in development·12 companies·0 clinical trials

Drug Pipeline by Phase

Approved(8)

Drug	Company
Amvuttra	Royalty Pharma plc (RPRX)
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
attruby	BridgeBio Pharma, Inc. (BBIO)
ONPATTRO	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
supplemental new drug	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
tegsedi	AKCEA THERAPEUTICS, INC. (AKCA)
Tegsedi	PTC THERAPEUTICS, INC. (PTCT)
wainua	ASTRAZENECA PLC (AZN)

Phase 3(8)

Drug	Company
alxn2060	ALEXION PHARMACEUTICALS, INC. (ALXN)
alxn2220	Hepion Pharmaceuticals, Inc. (CTRVP)
eplontersen	ASTRAZENECA PLC (AZN)
eplontersen	IONIS PHARMACEUTICALS INC (IONS)
NNC6019-0001	PROTHENA CORP PUBLIC LTD CO (PRTA)
Nucresiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Patisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Vutrisiran	ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Phase 2(2)

Drug	Company
alxn2220	ASTRAZENECA PLC (AZN)
nnc6019-0001	Novo Nordisk A/S (NVO)

Phase 1(3)

Drug	Company
ALN-TTRSC04	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
coramitug	Novo Nordisk A/S (NVO)
NTLA-2001	Intellia Therapeutics, Inc. (NTLA)

Preclinical(1)

Drug	Company
ag10	ALEXION PHARMACEUTICALS, INC. (ALXN)

Unknown(1)

Drug	Company
inotersen	AKCEA THERAPEUTICS, INC. (AKCA)

Compare drugs

Amvuttra vs attruby Amvuttra vs ONPATTRO Amvuttra vs supplemental new drug

Deep-dive into Transthyretin

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Transthyretin — Drugs in Development & Clinical Trials | BioSniper